Siemens Healthineers has finalized its deal to purchase radiopharmaceutical company Advanced Accelerator Applications Molecular Imaging from Novartis, the company announced Tuesday.
The property, which Siemens renamed Advanced Accelerator Applications, manufactures and distributes diagnostic radiopharmaceuticals for positron emission tomography scans. The Siemens Healthineers-Novartis deal is worth $224 million, Reuters reported.
Related: Siemens unveils 2 new lower-cost photon-counting CTs
The new unit builds on Siemens Healthineers’ molecular imaging business, PETNET Solutions, according to the company.
Novartis acquired Advanced Accelerator Applications for $3.9 billion in 2017, according to Reuters.
